Reinilde Heyrman
Chief Tech/Sci/R&D Officer at MEDPACE HOLDINGS, INC.
Profile
Reinilde Heyrman is currently the Chief Medical Officer at Medpace Holdings, Inc. She previously worked as the Chief Clinical Development Officer at Ikaria, Inc. and as the Secretary, Chief Clinical Development Officer & VP at Bellerophon Therapeutics, Inc. Heyrman earned a doctorate degree from the University of Antwerp.
Reinilde Heyrman active positions
| Companies | Position | Start |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2017 |
Former positions of Reinilde Heyrman
| Companies | Position | End |
|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | - |
| BELLEROPHON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Stock Market
- Insiders
- Reinilde Heyrman
